Different genes drive cancer growth in males and females.
Male and female tumors are different. Researchers are now hoping to exploit these sex-specific differences to treat brain cancer. This might improve survival for everyone.
There are lots of ways to support a friend through breast cancer. Sharing the journey is key, studies suggest.
People across the country show their support for breast cancer patients and survivors by wearing pink and raising money each October. A recent study of patients suggests ways to help all year.
Many cancer patients have chemotherapy after surgery, but not all of them actually need it.
We have no reliable way of knowing which patients' cancer will return after surgery, so often chemotherapy is given to mop up any remaining cancer cells that may have gone undetected.
Surviving breast cancer has been the biggest treatment goal until recent years, when attention began to turn to surviving well, as these three women appear to be.
While more women than ever are surviving breast cancer, they often do so with bad side effects. Studies are showing that physical therapy early in the post-treatment phase can help.
More than just a stomach bug.
Patients undergoing chemotherapy are at particular risk from food poisoning - but they aren't being made aware how critical food safety is at home.
Breast cancer tumours behave, and are treated, differently.
Headlines that 70% of women with breast cancer don't need chemo need to be heeded with caution: it's a very specific (but substantial) subtype that was studied.
We only know if a cancer has been cured in hindsight.
Photo by Kaylee Eden on Unsplash
A cancer is in remission when it can no longer be detected. But we only say it's cured when it hasn't come back for a certain time – and that differs for different cancers.
Circadian clocks regulate the timing of hundreds of processes in the cell, suggesting that matching medications with your biological clock could improve the outcome
Prostate cancer cell, viewed with a scanning electron microscope.
Cancer doesn't just grow uncontrollably. It has a smarter strategy than that.
A new silver-based compound that is less toxic with fewer side effects could hold the key to crippling cancer.
Collaborations between mathematicians, cancer biologists and clinical oncologists enable both rapid cost-effective testing of cancer drug combinations, and deeper understanding of cancer drug resistance.
Cancer is the second leading cause of death globally. Mathematicians have joined the fight, developing models to both test cancer drug combinations and understand chemotherapy drug resistance.
In this Dec. 3, 2014 photo, liver cancer patient Crispin Lopez Serrano talks to an oncology nurse at a hospital in Clackamas, Ore.
AP Photo/Gosia Wozniacka
Great strides have been made in cancer medicine over decades, but it's important not to forget the growing role that kindness and empathy play in good care.
AML under the microscope.
Medtech THAI STUDIO LAB 249
Improvements in survival rates for acute myeloid leukaemia have failed to keep pace with other leukaemias. That may be about to change.
Apple's Eyes Studio/Shutterstock.com
We need to ensure cancer research addresses what matters most.
Poor food safety at home could lead to serious consequences for those with suppressed immune systems.
Already suffering debilitating side effects, chemotherapy patients could be made seriously ill by the food they eat.
Acute myeloid leukemia is a type of cancer where the bone marrow makes abnormal myeloblasts, a type of white blood cell.
Medtech THAI STUDIO LAB 249/Shutterstock.com
AML can kill with surprising rapidity. Luckily new treatments are on the horizon.
Survival rates for childhood brain cancer have not improved for decades.
Leukaemia used to be a death sentence. Now, the survival rate for the most common form in children is 85%. We can apply similar strategies to how we approach childhood brain cancer.
Dr. Karen Lindfors, a professor of radiology and chief of breast imaging at the University of California, Davis Medical Center, examines the mammogram of a patient.
(AP Photo/Rich Pedroncelli)
The majority of research suggests the benefits of mammography screening greatly outweigh the harms for women over age 40.
A recent Canadian trial reports breast cancer over-diagnosis rates of up to 55 per cent, from routine screening mammograms.
October is breast cancer awareness month. Women should know there is no reliable evidence that routine mammograms reduce death from breast cancer, and there's good evidence that they cause harm.
The curse of survival.
A twinge can be all it takes to convince patients they have a new tumour